Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17619ExperimentalSmall molecule
Sinbaglustat: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Ceramide glucosyltransferase and Non-lysosomal glucosylceramidase
- Formula / weight
- C11H23NO4 · 233.308 g/mol (avg)
- Also known as
- (2s,3r,4r,5s)-2-(hydroxymethyl)-1-pentyl-3,4,5-piperidinetriol · (2S,3R,4R,5S)-2-(Hydroxymethyl)-1-Pentylpiperidine-3,4,5-Triol · 3,4,5-piperidinetriol, 2-(hydroxymethyl)-1-pentyl-, (2s,3r,4r,5s)-
- Code names
- ACT 519276 · (+)-OGT-2378
Resolves to
Structure
InChIKey
HCZQIIVHWYFIPW-UKKRHICBSA-NSMILESCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@@H]1COTargets
What you can answer from here — as of July 08, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Sinbaglustat, and which of those have an active Phase 3 trial?